| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |